budesonide + metronidazole

Budesonide + metronidazole is a combination of two pharmaceutical agents, each with distinct mechanisms of action. Budesonide is a synthetic glucocorticoid corticosteroid that acts as an anti-inflammatory agent by binding to the glucocorticoid receptor and modulating gene expression, thereby reducing inflammation in conditions such as Crohn's disease and ulcerative colitis. Metronidazole is a nitroimidazole antimicrobial that exerts its effect by disrupting DNA synthesis in susceptible anaerobic bacteria and protozoa, leading to cell death. This combination has been studied for use in inflammatory bowel diseases, particularly Crohn's disease involving the colon or perianal region, where both anti-inflammatory and antimicrobial effects may be beneficial[2][4]. However, clinical trials have shown mixed efficacy for this combination compared to monotherapy with budesonide[4].